New pill aims to stop stomach bug in its tracks
Disease control
Recruiting now
This study tests an experimental oral drug called CDI-988 in 40 healthy adults aged 18 to 49. Participants receive either the drug or a placebo before being exposed to norovirus, the highly contagious stomach bug. The goal is to see if CDI-988 reduces vomiting and diarrhea compar…
Phase: PHASE1, PHASE2 • Sponsor: Cocrystal Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC